Cite
HARVARD Citation
Lederman, S. et al. (n.d.). Phase 3 Study of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause [A132]. Obstetrics and gynecology. p. 39S. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lederman, S. et al. (n.d.). Phase 3 Study of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause [A132]. Obstetrics and gynecology. p. 39S. [Online].